341 filings
15-12G
PLXPQ
PLx Pharma Winddown Corp.
18 Oct 23
Securities registration termination
4:01pm
8-K
PLXPQ
PLx Pharma Winddown Corp.
20 Sep 23
Bankruptcy or Receivership
4:39pm
8-K
PLXPQ
PLx Pharma Winddown Corp.
22 Aug 23
Other Events
5:24pm
8-K
PLXPQ
PLx Pharma Winddown Corp.
21 Jul 23
Other Events
5:29pm
8-K
PLXPQ
PLx Pharma Winddown Corp.
12 Jul 23
Other Events
12:00am
8-K
5szruww74
7 Jul 23
Departure of Directors or Certain Officers
4:16pm
8-K
kl9abxi xbviu1l4
27 Jun 23
Other Events
4:47pm
8-K
zf7tchd
26 May 23
Entry into a Material Definitive Agreement
4:19pm
25-NSE
krltw7ikpq5 qmhh0
2 May 23
Exchange delisting
1:35pm
8-K
vg1mmk9sbhish2tkj1l
13 Apr 23
Bankruptcy or Receivership
4:38pm
8-K
8sfh 2wounio
12 Apr 23
PLx Pharma Inc. Enters into a Stalking Horse Asset Purchase Agreement to Sell VAZALORE® and Substantially All of its Assets
5:29pm
8-K
jr91x8pskegp
10 Apr 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
SC 13G
o591 p4qq
6 Apr 23
PLx Pharma / Park West Asset Management ownership change
9:15am
8-K
1fpd00khw7
8 Mar 23
Departure of Directors or Certain Officers
4:42pm
SC 13G/A
y0bo8 izl
14 Feb 23
PLx Pharma / MSD Partners ownership change
1:38pm
8-K
8jn 2gie49a7
13 Feb 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:16pm
8-K
q494p52jyj3l
20 Jan 23
Departure of Directors or Certain Officers
5:00pm
8-K
x6wiv38 63ks4xt
10 Nov 22
PLx Pharma Inc. Reports Third Quarter 2022 Results and Provides Business Update
5:12pm
8-K
m3egn42
7 Oct 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:45pm